APEMARS News
APEMARS Launches Stage 3 Presale at $0.00002448, Highlighting Asymmetric Investment Opportunity
APEMARS APRZ Launches Presale with 22,367% Potential ROI
APEMARS Opens Whitelist, Early Participants Could See 25x Returns
APEMARS Launches Early Whitelist for 63% APY Staking Rewards
APEMARS Attracts Investor Attention with Whitelist-First Presale Model
APEMARS Whitelist Phase Offers 32,000% Potential ROI
